Shopping Cart 0
Cart Subtotal
AED 0

MediPoint: Viscosupplementation-South America Analysis and Market Forecasts

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 18350

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 36700

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 55050

Details

MediPoint: Viscosupplementation-South America Analysis and Market Forecasts

Summary

Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability around the world. Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint's cartilage and bone hypertrophy. The disability is accompanied by joint pain, stiffness, and loss of range of motion. Initially treated with various therapies including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs), advanced cases of OA have traditionally been treated surgically. However, intra-articular viscosupplementation with hyaluronic acid (HA), a high-molecular-weight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade.

This report focuses on the market outlook for viscosupplementation products in South America (Argentina, Brazil, and Chile). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.

Key Questions Answered

What is the current and future viscosupplementation market outlook in the developed and emerging markets? What trends are affecting the South American market?

Which are the key, high growth markets that viscosupplementation manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?

What are the unmet needs with the current generation of viscosupplementation products? How will emerging technologies fulfill these unmet needs?

What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for viscosupplementation?

What are the challenges and complications that have hindered widespread adoption?

With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the viscosupplementation market?

Scope

Overview of recent key industry events and analysis of their market impact.

Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.

Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.

Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.

Analysis of the current and future market competition in the South American viscosupplementation market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to-

Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

Develop business strategies by understanding the trends shaping and driving the viscosupplementation market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the viscosupplementation market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in country-specific viscosupplementation markets from 2014-2023.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

READ MORE

Table Of Content

Scope

Table of Contents

1 About the Authors 2

1.1 Analysts 2

1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices 2

1.1.2 Linda Tian, Managing Analyst, Medical Devices 2

1.1.3 Global Head of Medical Devices 2

2 Table of Contents 3

2.1 List of Tables 5

2.2 List of Figures 5

3 Executive Summary 6

3.1 Overview 6

3.2 Market Dynamics 7

3.3 Key Players in the Viscosupplementation Market 8

3.4 Viscosupplementation Market Future Outlook 8

4 Introduction 9

4.1 Catalyst 9

4.2 Related Reports 9

4.3 Upcoming Related Reports 10

5 Market Outlook 11

5.1 Procedure Trends 11

5.2 Pricing Trends 11

5.3 Revenue Trends 12

5.4 Company Share Analysis 12

6 Market Insights 13

6.1 South America 13

6.1.1 Brazil 13

6.1.2 Argentina and Chile 13

7 Competitive Assessment 14

7.1 Overview 14

7.2 Anika Therapeutics 14

7.2.1 Overview 14

7.2.2 Portfolio Assessment 15

7.2.3 Competitive Positioning 15

7.3 Ferring Pharmaceuticals 15

7.3.1 Overview 15

7.3.2 Portfolio Assessment 16

7.3.3 Competitive Positioning 16

7.4 Fidia Farmaceutici 16

7.4.1 Overview 16

7.4.2 Portfolio Assessment 16

7.4.3 Competitive Positioning 17

7.5 Sanofi 18

7.5.1 Overview 18

7.5.2 Portfolio Assessment 18

7.5.3 Competitive Positioning 18

7.6 Other Players 19

8 Appendix 21

8.1 Bibliography 21

8.2 Abbreviations 21

8.3 Methodology 22

8.3.1 Overview 22

8.3.2 Coverage 22

8.3.3 Secondary Research 22

8.3.4 Forecasting Methodology 23

8.3.5 Primary Research Summary 24

8.4 About MediPoint 25

8.5 About GlobalData 25

8.6 Contact Us 25

8.7 Disclaimer 26


List Of Figure

List of Figures

Figure 1: Viscosupplementation Sales for South America, by Country, 2016 and 2023 7


List Of Table

List of Tables

Table 1: Key Metrics in the South America Viscosupplementation Market 6

Table 2: South America Viscosupplementation Volume Forecast, 2014-2023 11

Table 3: South America Viscosupplementation Average Selling Price Forecast ($), 2014-2023 11

Table 4: South America Viscosupplementation Market Revenue Forecast ($M), 2014-2023 12

Table 5: South America Viscosupplementation Company Share Analysis, 2016 12

Table 6: Anika Therapeutics-Key Marketed Products Assessment 15

Table 7: Ferring Pharmaceuticals-Key Marketed Products Assessment 16

Table 8: Fidia Farmaceutici-Key Marketed Products Assessment 16

Table 9: Fidia Farmaceutici-Key Clinical Trials 17

Table 10: Sanofi-Key Marketed Products Assessment 18

Table 11: Summary of Other Players in the Viscosupplementation Market, 2017 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Anika Therapeutics, Ferring Pharmaceuticals, Fidia Farmaceutici, Sanofi, Seikagaku Corporation

Company Profile

Company Profile Title

MediPoint: Viscosupplementation-South America Analysis and Market Forecasts

Summary

Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability around the world. Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint's cartilage and bone hypertrophy. The disability is accompanied by joint pain, stiffness, and loss of range of motion. Initially treated with various therapies including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs), advanced cases of OA have traditionally been treated surgically. However, intra-articular viscosupplementation with hyaluronic acid (HA), a high-molecular-weight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade.

This report focuses on the market outlook for viscosupplementation products in South America (Argentina, Brazil, and Chile). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.

Key Questions Answered

What is the current and future viscosupplementation market outlook in the developed and emerging markets? What trends are affecting the South American market?

Which are the key, high growth markets that viscosupplementation manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?

What are the unmet needs with the current generation of viscosupplementation products? How will emerging technologies fulfill these unmet needs?

What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for viscosupplementation?

What are the challenges and complications that have hindered widespread adoption?

With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the viscosupplementation market?

Scope

Overview of recent key industry events and analysis of their market impact.

Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.

Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.

Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.

Analysis of the current and future market competition in the South American viscosupplementation market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to-

Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

Develop business strategies by understanding the trends shaping and driving the viscosupplementation market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the viscosupplementation market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in country-specific viscosupplementation markets from 2014-2023.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

READ MORE

Scope

Table of Contents

1 About the Authors 2

1.1 Analysts 2

1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices 2

1.1.2 Linda Tian, Managing Analyst, Medical Devices 2

1.1.3 Global Head of Medical Devices 2

2 Table of Contents 3

2.1 List of Tables 5

2.2 List of Figures 5

3 Executive Summary 6

3.1 Overview 6

3.2 Market Dynamics 7

3.3 Key Players in the Viscosupplementation Market 8

3.4 Viscosupplementation Market Future Outlook 8

4 Introduction 9

4.1 Catalyst 9

4.2 Related Reports 9

4.3 Upcoming Related Reports 10

5 Market Outlook 11

5.1 Procedure Trends 11

5.2 Pricing Trends 11

5.3 Revenue Trends 12

5.4 Company Share Analysis 12

6 Market Insights 13

6.1 South America 13

6.1.1 Brazil 13

6.1.2 Argentina and Chile 13

7 Competitive Assessment 14

7.1 Overview 14

7.2 Anika Therapeutics 14

7.2.1 Overview 14

7.2.2 Portfolio Assessment 15

7.2.3 Competitive Positioning 15

7.3 Ferring Pharmaceuticals 15

7.3.1 Overview 15

7.3.2 Portfolio Assessment 16

7.3.3 Competitive Positioning 16

7.4 Fidia Farmaceutici 16

7.4.1 Overview 16

7.4.2 Portfolio Assessment 16

7.4.3 Competitive Positioning 17

7.5 Sanofi 18

7.5.1 Overview 18

7.5.2 Portfolio Assessment 18

7.5.3 Competitive Positioning 18

7.6 Other Players 19

8 Appendix 21

8.1 Bibliography 21

8.2 Abbreviations 21

8.3 Methodology 22

8.3.1 Overview 22

8.3.2 Coverage 22

8.3.3 Secondary Research 22

8.3.4 Forecasting Methodology 23

8.3.5 Primary Research Summary 24

8.4 About MediPoint 25

8.5 About GlobalData 25

8.6 Contact Us 25

8.7 Disclaimer 26


List Of Figure

List of Figures

Figure 1: Viscosupplementation Sales for South America, by Country, 2016 and 2023 7


List Of Table

List of Tables

Table 1: Key Metrics in the South America Viscosupplementation Market 6

Table 2: South America Viscosupplementation Volume Forecast, 2014-2023 11

Table 3: South America Viscosupplementation Average Selling Price Forecast ($), 2014-2023 11

Table 4: South America Viscosupplementation Market Revenue Forecast ($M), 2014-2023 12

Table 5: South America Viscosupplementation Company Share Analysis, 2016 12

Table 6: Anika Therapeutics-Key Marketed Products Assessment 15

Table 7: Ferring Pharmaceuticals-Key Marketed Products Assessment 16

Table 8: Fidia Farmaceutici-Key Marketed Products Assessment 16

Table 9: Fidia Farmaceutici-Key Clinical Trials 17

Table 10: Sanofi-Key Marketed Products Assessment 18

Table 11: Summary of Other Players in the Viscosupplementation Market, 2017 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Anika Therapeutics, Ferring Pharmaceuticals, Fidia Farmaceutici, Sanofi, Seikagaku Corporation